Akribion Genomics
Zwingenberg
About Akribion Genomics
Akribion Genomics develops gene-editing tools and cancer therapies using CRISPR nuclease technology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $8.3M
- Funding stage: Seed
- Last round: Seed (Feb 2025)
- Website: akribion-genomics.com
Industries & Categories
Biotechnology, Health Care, Oncology
Social Profiles
Canonical: https://fsome.com/organization/akribion-genomics-94559 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.